Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 72789-115

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 72789-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789115 Label (72789115)

Cyclobenzaprine HCL USP 5 mg film-coated tablet label from PD-Rx Pharmaceuticals, Inc. This prescription drug label includes a barcode, drug name, strength, and quantity of 20 tablets. It provides warnings about drowsiness and caution while driving, with dosage instructions and reorder information. Label features the NDC 72789-115-20 and expiration date 12/2021.*

FDA Label Image

Structural Formula For Cyclobenzaprine. (Cyclobenzaprine 1)

Chemical structure of cyclobenzaprine hydrochloride, showing a tricyclic compound with associated hydrochloride salt component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.